Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Remedium Lifecare has informed that the Company has received a multi-year supply contract from a pharmaceutical distribution company based in the United Kingdom. The contract involves the supply of various Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty Chemicals. The supplies scheduled between July 2024 and June 2025 alone are valued at one hundred seventy-five crore rupees. Pursuant to SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015, Disclosure given as Annexure A.
The above information is a part of company’s filings submitted to BSE.
